Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
ConclusionAlthough this is an observational analysis of non-randomized treatment, there was no suggestion that CCBs were associated with worse HF outcomes. Indeed, CCB use was associated with a lower incidence of pump failure death. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 6, 2023 Category: Cardiology Authors: Shingo Matsumoto,
Toru Kondo,
Mingming Yang,
Ross T. Campbell,
Kieran F. Docherty,
Rudolf A. de Boer,
Akshay S. Desai,
Carolyn S.P. Lam,
Milton Packer,
Bertram Pitt,
Jean L. Rouleau,
Muthiah Vaduganathan,
Faiez Zannad,
Michael R. Zile,
Scott Tags: Research Article Source Type: research
Safety of Continuing Mineralocorticoid Receptor Antagonists Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry
ConclusionsThe use of MRAs in patients with HFrEF decreased with worse renal function; however their safety profile was demonstrated to be consistent across the entire eGFR spectrum.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 5, 2023 Category: Cardiology Authors: Federica Guidetti,
Lars H Lund,
Lina Benson,
Camilla Hage,
Francesca Musella,
Davide Stolfo,
Peter G.M. Mol,
Andreas J Flammer,
Frank Ruschitzka,
Ulf Dahlstrom,
Giuseppe M C Rosano,
Oscar Ö Braun,
Gianluigi Savarese Tags: Research Article Source Type: research
Tafamidis in Patients with Severe Heart Failure Due to Transthyretin Amyloidosis Cardiomyopathy: Improved Long ‐term Survival
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 5, 2023 Category: Cardiology Authors: Alwin Tubben,
Hans L.A. Nienhuis,
Peter van der Meer Tags: Invited Editorial Source Type: research
Non ‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial
ConclusionsIn the STRONG-HF trial, NCCs neither limited the rapid up-titration of HF therapies, nor attenuated the benefit of HIC on the primary endpoint. In the context of a clinical trial, the benefit –risk ratio favours the rapid up-titration of HF therapies even in patients with multiple NCCs. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 4, 2023 Category: Cardiology Authors: Ovidiu Chioncel,
Beth Davison,
Marianna Adamo,
Laura E. Antohi,
Mattia Arrigo,
Marianela Barros,
Jan Biegus,
Kamil ė Čerlinskaitė‐Bajorė,
Jelena Celutkiene,
Alain Cohen‐Solal,
Albertino Damasceno,
Rafael Diaz,
Christopher Edwards,
Ger Tags: Research Article Source Type: research
Reply to ‘Effects of tafamidis on heart failure hospitalization: The tale of the dog that did not bark
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 4, 2023 Category: Cardiology Authors: Perry Elliott,
Balarama Gundapaneni,
Pablo Garcia ‐Pavia Tags: Letter to the Editor Source Type: research
Striving for the “Perfect” Definition of Iron Deficiency in Heart Failure
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 4, 2023 Category: Cardiology Authors: Jan Biegus,
Piotr Ponikowski Tags: Invited Editorial Source Type: research
Personalizing Anti ‐Inflammatory Therapy in Heart Failure: A New Way
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 4, 2023 Category: Cardiology Authors: Domingo Pascual ‐Figal,
Jose Javier Fuster,
Antoni Bayes‐Genis Tags: Invited Editorial Source Type: research
Sodium –glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease — No heterogeneity
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 4, 2023 Category: Cardiology Authors: Camilla Hage,
Lars H. Lund Tags: Invited Editorial Source Type: research
Reply to ‘Phenotypic characterization of heart failure with preserved ejection fraction’
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - October 3, 2023 Category: Cardiology Authors: Yuki Saito,
Masaru Obokata Tags: Letter to the Editor Source Type: research
Venting strategies for extracorporeal membrane oxygenation patients: More questions than answers but a plea for more clinical trials on the topic!
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Cl ément Delmas,
Aurore Ughetto,
Guillaume Lebreton,
François Roubille Tags: Letter to Editor Source Type: research
Sodium –glucose co‐transporter 2 inhibitors in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease – no heterogeneity
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Camilla Hage,
Lars H Lund Tags: Invited Editorial Source Type: research
Calcium channel blocker and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
ConclusionAlthough this is an observational analysis of non-randomized treatment, there was no suggestion that CCBs were associated with worse HF outcomes. Indeed, CCB use was associated with a lower incidence of pump failure death.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Shingo Matsumoto,
Toru Kondo,
Mingming Yang,
Ross T Campbell,
Kieran F. Docherty,
Rudolf A. Boer,
Akshay S. Desai,
Carolyn S.P. Lam,
Milton Packer,
Bertram Pitt,
Jean L. Rouleau,
Muthiah Vaduganathan,
Faiez Zannad,
Michael R. Zile,
Scott D. Tags: Research Article Source Type: research
Watchful Waiting for Venting in Venoarterial Extracorporeal Membrane Oxygenation
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Julie KK Vishram ‐Nielsen,
Finn Gustafsson Tags: Invited Editorial Source Type: research
Impact of COVID ‐19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial
ConclusionDELIVER is one of the most extensive experiences with COVID-19 of any cardiovascular trial, with>75% of follow-up time occurring during the pandemic. COVID-19 was common, with>50% of cases leading to hospitalization or death. Treatment benefits of dapagliflozin persisted when censoring at COVID-19 diagnosis and pandemic onset. Patients surviving COVID-19 event had a high early residual risk.This article is protected by copyright. All rights reserved. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Ankeet S. Bhatt,
Mikhail N. Kosiborod,
Brian L. Claggett,
Zi Michael Miao,
Muthiah Vaduganathan,
Carolyn S.P. Lam,
Adrian F. Hernandez,
Felipe A. Martinez,
Silvio E Inzucchi,
Sanjiv J. Shah,
Rudolf A. Boer,
Pardeep S. Jhund,
Akshay S. Desai,
Tags: Research Article Source Type: research
Response by Elliott et al to Letter Regarding Article: Effects of Tafamidis on Heart Failure Hospitalization: The Tale of The Dog That Did Not Bark
(Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - September 29, 2023 Category: Cardiology Authors: Perry Elliott,
Balarama Gundapaneni,
Pablo Garcia ‐Pavia Tags: Letter to Editor Source Type: research
